GSK Unveils New UTI Antibiotic Blujepa After Decade-Long Gap
GlaxoSmithKline (GSK) has brought a new era to urinary tract infection (UTI) treatment with its antibiotic Blujepa, the first oral antibiotic in nearly 30 years. The FDA has cleared Blujepa for treating uncomplicated UTIs caused by specific bacteria in women aged 12 and older. According to GSK, more than half of women will experience a … Read more